Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

TENX

$1.83-1.61%website ↗⬇ financials (.py)

TENAX THERAPEUTICS, INC.

Market Cap
$80M
Sector
Materials
Industry
Biotechnology
Beta
0.99
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
25.6x
buying
Congress
—
recent trades
Short Volume
45%
W/W +10.4pp

Market & Alt Data

News
15
recent articles
Activist
13D
Giordano
Analyst Consensus
Buy
16 analysts
Velocity Score
25.65x
Current Rate (90d)
30141.39/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
3
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-09-152026-09-15Giordano Christopher ThomasDirector & CEOPurchase4,850$1.82$9K22.2KView
2026-09-112026-09-15STAAB THOMAS R IIChief Financial OfficerPurchase5,675$1.94$11K15.7KView
2026-09-112026-09-15Giordano Christopher ThomasDirector & CEOPurchase6,000$1.88$11K17.3KView
2026-09-032026-09-08ADAR1 Capital Management, LLC10% OwnerPurchase900.0K$1.78$1.60M6.52MView
2026-09-022026-09-02ADAR1 Capital Management, LLC10% OwnerPurchase187.7K$1.80$338K5.62MView
1–5 of 10
1 / 2

Recent News

Tenax Therapeutics, Inc. (TENX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference - Slideshow
SeekingAlpha · 2026-09-09
Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable?
Yahoo · 2026-09-04
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Yahoo · 2026-09-01
5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month
Benzinga · 2026-09-01

Informational purposes only, not investment advice.

TENAX THERAPEUTICS, INC. (TENX)

tormere.com/research/TENX · generated 2026-09-16

$1.83
-1.61%
General Information
Price$1.83
Change-1.61%
Market Cap$80M
SectorMaterials
IndustryBiotechnology
ExchangeNasdaq
Beta (5yr vs SPY)0.99
Signals
Insider Velocity25.6x buying
Congress Trades—
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
Yahoo · 2026-08-31
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 2026-08-31
This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Benzinga · 2026-08-31
Guggenheim Downgrades Tenax Therapeutics to Neutral
Benzinga · 2026-08-31
Reported Earlier, Tenax Reports New Phase 3 Data Supporting TNX-103 In Pulmonary Hypertension Patients
Benzinga · 2026-08-31
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026
Yahoo · 2026-08-29
Let's uncover which stocks are experiencing notable gaps during today's session.
ChartMill · 2026-08-25
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 2026-08-25
Tenax Therapeutics’ stock crashes on Phase III trial failure
Yahoo Finance · 2026-08-11
Tenax Therapeutics Phase 3 LEVEL Trial Misses Primary Endpoint for TNX-103
Yahoo Finance · 2026-08-10
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Yahoo Finance · 2026-07-31
Short Volume
45% of daily vol
Conviction Score57/100
Analyst ConsensusSB 3 · B 8 · H 5 · S 0 · SS 0
Price Chart (1 Year)
2025-09-162026-09-15$18.32$1.38
Recent Insider Activity (Form 4) — Last 5
DateInsiderTypeSharesValue
2026-09-15Giordano Christopher ThomasP4,850$8,837.19
2026-09-11STAAB THOMAS R IIP5,675$10,981.13
2026-09-11Giordano Christopher ThomasP6,000$11,250
2026-09-03ADAR1 Capital Management, LLCP900,000$2M
2026-09-02ADAR1 Capital Management, LLCP187,704$337,585.64
Recent News
  • Tenax Therapeutics, Inc. (TENX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference - Slideshow — SeekingAlpha · 2026-09-09
  • Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable? — Yahoo · 2026-09-04
  • Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference — Yahoo · 2026-09-01
  • 5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Month — Benzinga · 2026-09-01
  • Deere upgraded, Lumentum initiated: Wall Street's top analyst calls — Yahoo · 2026-08-31

Tormere — informational purposes only, not investment advice.

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →
Pipeline
Phase 3
2 active trials